Feline mammary tumours in comparative oncology

Journal of Dairy Research

Volumn 72, Issue SPEC. ISS., 2005, Pages 98-106

  Zappulli, Valentina ^a   De Zan, Gabrita ^a   Cardazzo, Barbara ^a   Bargelloni, Luca ^a   Castagnaro, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Comparative oncology; Feline mammary tumours; Mammary gland

Indexed keywords

HORMONE;

ANIMAL; CAT; CAT DISEASE; COMPARATIVE STUDY; DISEASE MODEL; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; HISTOLOGY; MALE; ONCOLOGY; PATHOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; UDDER;

ANIMALS; CAT DISEASES; CATS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HORMONES; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MEDICAL ONCOLOGY; PROGNOSIS; RISK FACTORS;

FELIDAE;

EID: 24944473809     PISSN: 00220299     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0022029905001263     Document Type: Review

References (88)

1. Bacha WJ & Bacha LM Jr 2000 Color Atlas of Veterinary Histology Second Edition. New York: Lippincott Williams & Wilkins.
2. Bargelloni L, Zappulli V, Petterino C, Patarnello T, Castagnaro M 2002 Isolation and sequencing of estrogen-receptor alpha cDNA in the cat: potentials for comparative oncology and molecular diagnostics. Proceedings of the 20th ESVP Meeting, Grugliasco (TO) Italy, 18-21 Sept
3. Barton MB, Elmore JG, Fletcher SW 1999 Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation and outcome. Annals of Internal Medicine 130 651-657
4. Boova RS, Bonanni R, Rosato FE 1982 Patterns of axillary nodal involvement in breast cancer: predictability of level one dissection. Annals of Surgery 196 642-644
5. Bostock DE, Moriarty J & Crocker J 1992 Correlation between histologic diagnosis, mean nucleolar organiser region count and prognosis in canine mammary tumours. Veterinary Pathology 29 381-385
6. Cappelletti V, Granata G, Miodini P, Coradini D 1988 Modulation of receptor levels in canine breast tumours by administration of tamoxifen and etretinate either alone or in combination Anticancer Research 8 1297-1301
7. Carter RF 2001 BRCA1, BRCA2 and breast cancer: a concise clinical review. Clinical and Investigative Medicine 24 147-157
8. Castagnaro M, Casalone C, Bozzetta E, De Maria R, Biolatti B, Caramelli M 1998a Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas. Journal of Comparative Pathology 119 263-275
9. Castagnaro M, Casalone C, Ru G, Nervi GC, Bozzetta E, Caramelli M 1998b Argyrophilic nucleolar organizer regions (AgNOR) count as indicator of post-surgical prognosis in feline mammary carcinomas. Research in Veterinary Science 64 97-100.
10. Castagnaro M, De Maria R, Bozzetta E, Ru G, Casalone C, Biolatti B, Caramelli M 1998c Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. Research in Veterinary Science 65 223-226.
11. Crouch JE & Lackey MB 1969 The mammary gland - Its structure, relationships and blood supply. In: Text-Atlas of Cat Anatomy, p. 183 (Eds Crouch JE & MB Lackey). Philadelphia: Lea & Febinger
12. De Maria R, Iussich S, Olivero M, Di Renzo MF, Biolatti B 2003 Her2/neu oncogene expression in feline mammary carcinomas. Proceedings of the 21st ESVP Meeting, Dublin, Ireland, 13 Sept
13. De Maria R, Maggiore P, Biolatti B, Prat M, Ciomoglio PM, Castagnaro M & Di Renzo MF 2002 Feline STK gene expression in mammary carcinomas. Oncogene 21 1785-1790
14. Dias Pereira P & Gartner F 2003 Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue. Veterinary Record 153 297-302
15. Dincer Z, Jasani B, Haywood S, Mullins JE, Fuentealba JC 2001 Metallothionein expression in canine and feline mammary and melanotic tumours. Journal of Comparative Pathology 125 130-136
16. Dorn CR, Taylor DON, Schneider R, Hibbard HH & Klauber MR 1968 Survey of animal neoplasms in Alameda and Contra Costas counties, California. II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute 40 307-318
17. Elston CW & Ellis IO 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 403-410
18. Fletcher CDM 1995 Diagnostic Histopathology of Tumors Volume 1. New York: Churchill Livingstone
19. Fowler EH, Wilson GP, Koestern AA 1974 Biologic behaviour of canine mammary neoplasm based on a histogenic classification. Veterinary Pathology 11 212-229
20. Fuqua SAW, Schiff R, Parra I, Moore JT, Mohsin SK, Osborne CK, Clark GM & Allred DC 2003 Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters. Cancer Research 63 2434-2439
21. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ 1989 Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Journal of the National Cancer Institute 81 1879-1886
22. Giordano SH, Buzdar AU, Hortobagyi GN 2002 Breast cancer in men. Annals of Internal Medicine 137 678-687
23. Goldhirsch A, Glick JH, Gelber RD, Coates AS & Senn H-J 2001 Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. Journal of Clinical Oncology 19 3817-3827
24. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M 2002 AJCC Cancer Staging Manual, 6th edition. New York: Sprinter
25. Hahn KA, Bravo L & Avenell JS 1994 Feline breast carcinoma as a pathologic and therapeutic model for human breast cancer. In Vivo 8 825-828
26. Hamajima N et al. 2002 Alcohol, tobacco and breast cancer: collaborative reanalysis of individual data form 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease. British Journal of Cancer 87 1234-1245
27. Hansen K & Khanna C 2004 Spontaneous and genetically engineered animal models: use in preclinical cancer drug development. Europena Journal of Cancer 40 858-880
28. Hayden DW & Nielsen SW 1971 Feline mammary tumours. Journal of Small Animal Practice 12 687-698
29. Hayden DW, Johnstone SD & Kiang DT et al. 1981 Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects. American Journal of Veterinary Research 42 1699-1703
30. Hayes AH & Mooney BA 1985 Feline Mammary Tumors. Symposium on Clinical Veterinary Oncology. Veterinary Clinics of North America: Small Animal Practice 15 513-520
31. Hayes DF & Thor AD 2002 C-erbB-2 in breast cancer: development of a clinically useful marker. Seminars in Oncology 29 231-245
32. Hayes HM, Milne KL & Mandell CP 1981 Epidemiological features of feline mammary carcinoma. Veterinary Record 108 476-479
33. Hayes, Misdorp W, Romijn A & Hart AA 1992 The significance of ovariectomy and progestagens in the development of mammary carcinoma in cat. Tijdschr Diergeneeskd 117 2-4
34. Hirata S, Shoda T, Kato J, Hoshi K 2003 Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends in Endocrinology and Metabolism 14 124-129
35. Ito T, Kadosawa T, Mochizuki M, Matsunaga S, Nishimura R & Sasaki N 1996 Prognosis of malignant mammary tumours in 53 cats. Journal of Veterinary Medical Science 58 723-726
36. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ 2003 Cancer statistics, 2003. Cancer Journal for Clinicians 53 5-26
37. Johnston SD, Hayden DW, Kiang DT, Handschein B & Johnson KH 1984 Progesterone receptors in feline mammary adenocarcinoma. American Journal of Veterinary Research 45 379-382
38. Johnston SRD, Saccani-Jotti G, Smith IE, Salter J et al. 1995 Changes in estrogen receptor. Progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer. Cancer Research 55 3331-3338
39. Kumar V, Abbas AK, Fausto N 2004 Robbins and Cotran Pathologic Basis of Disease. 7th Edn Elsevier Saunders
40. Kurtzman ID & Gilbertson SR 1996 Prognostic factors in canine mammary tumours. Seminars of Veterinary Medicine and Surgery 1 25-32
41. Lantinga-van Leewen IS, van Gardeen E, Rutteman GR & Mol JA 2000 Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland. Journal of Steroid Biochemistry and Molecular Biology 75 219-228
42. Lara JF, Young SM, Velilla RE, Santoro EJ & Templeton SF 2003 The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer 98 2105-2113
43. MacEwen EG, Hayes AA, Harvey HJ, Patnaik AK, Mooney S & Passe S 1984 Prognostic factors for feline mammary tumors. Journal of the American Veterinary Medical Association 2 201-204
44. MacEwen EG 1990 Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer and Metastasis Review 9 125-136
45. MacEwen EG & Withrow SJ 1996 Tumours of the mammary gland. In: Small Animal Clinical Oncology, pp. 576-602 (Eds SJ Withrow & EG MacEwen). Philadelphia PA, USA: WB Saunders Company
46. Mahavni V & Sood Anil K 2001 Hormones replacement therapy and cancer risk. Current Opinion in Oncology 13 384-389
47. Martin de las Mulas JM, van Niel M, Millan Y, Blankenstein MA, van Mil F & Misdorp W 2002b Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domestic Animal Endocrinology 18 111-125
48. Martin de las Mulas M, Millan Y, Bautista MJ, Perez J & Carrasco L 2000 Estrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Research in Veterinary Science 68 15-21
49. Martin de las Mulas M, van Niel M, Millan Y, Ordas J, Blankenstein MA, van Mil F & Misdorp W 2002 Progesterone receptors in normal, dysplasic and tumourous feline mammary glands. Comparison wit oestrogen receptors status. Research in Veterinary Science 72 153-161
50. Martin PM, Cotard M, Mialot JP, Andre F & Raynaud JP 1984 Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemotherapy and Pharmacology 12 13-17
51. Meuten DJ 2002 Tumours in Domestic Animals. Ames Iowa: Iowa State University Press
52. Millanta F, Lazzeri G, Mazzei M, Vannozzi I & Poli A 2002 MIB-1 labeling index in feline dysplastic and neoplastic mammary leisons and its relationship with postsurgical prognosis. Veterinary Pathology 39 120-126
53. Millanta F, Lazzeri G, Vannozzi I, Viacava P, Poli A 2002 Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. Veterinary Pathology 39 690-696
54. Misdorp W, Else RW, Hellmen E & Lipscomb TP 1999 WHO International Histological Classification of Tumors of Domestic Animals. Histological classification of mammary tumors of the dog and the cat. 2nd series, volume VII. Washington DC: Armed Forces Institute of Pathology
55. Misdorp W, Romijn A & Hart AA 1991 Feline mammary tumors: a case-control study of hormonal factors. Anticancer Research 11 1793-1797
56. Misdorp W 1991 Progestagens and mammary tumours in dogs and cats. Acta Endocrinologica (Copenhagen) 125 27-31
57. Morris JS, Dobson JM, Bostock DE 1993 Use of tamoxifen in the control of canine mammary neoplasia. Veterinary Record 133 539-542
58. Mosselman S, Polman J & Dijkema R 1996 ER beta: identification and characterization of a novel human estrogen receptor. FEBS Letters 392 49-53
59. Murakami Y, Tateyama S, Rungsipipat A, Uchida K & Yamaguchi R 2000a Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats. Journal of Veterinary Medical Science 62 743-750
60. Murakami Y, Tateyama S, Rungsipipat A, Uchida K & Yamaguchi R 2000b Amplification of the cyclin A gene in canine and feline mammary tumors. Journal of Veterinary Medical Science 62 783-787
61. Nakopoulou L, Lazaris AC, Panayotopoulou EG, Giannopoulou I, Givalos N, Markaki S & Keramepoulos A 2004 The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer. Journal of Clinical Pathology 57 523-528
62. Nasir L, Krasner H, Argyle DJ & Williams A 2000 Immunocytochemical analysis of the tumour suppressor protein (p53) in feline neoplasia. Cancer Letters 155 1-7
63. Nelson HD, Humphrey LL, Nygren P, Teutsch SM & Allan JD 2002 Postmenopausal hormone replacement therapy: scientific review. Journal of the American Medical Association 288 872-881
64. Oonuma T, Morimatsu M, Nakagawa T, Uyama R, Sasaki N, Nakaichi M, Tamamura H, Fujii N, Hashimoto S, Yamamura H, Syuto B 2003 Role of CXCR4 and SDF-1 in mammary tumor metastasis in the cat. Journal of Veterinary Medical Science 65 1069-1073
65. Owen LN 1980 TNM Classification of Tumours in Domestic Animals. World Health Organization, Geneva
66. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S et al. 2002 Estrogen receptor beta in breast cancer. Endocrine-Related Cancer 9 1-13
67. Perez-Alenza MD, Jimenez A, Nieto AI & Pena L 2004 First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases. Breast Cancer Research 6 R300-R307
68. Martin PM, Cotard M, Mialot JP, Andre F & Raynaud JP 1984 Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemotherapy and Pharmacology 12 13-17
69. Preziosi R, Sarli G, Benazzi C & Marcato PS 1995 Detection of proliferatine cell nuclear antigen (PCNA) in canine and feline mammary tumours. Journal of Comparative Pathology 113 301-313
70. Rhodes DJ 2002 Identifying and counselling women at increased risk for breast cancer. Mayo Clinic Proceedings 77 355-360
71. Russo IH & Russo J 1987 Biology of disease. Biological and molecular basis of mammary carcinogenesis. Laboratory Investigation 75 112-137
72. Rutteman GR, Blankenstein MA, Minke JMHM & Misdorp W 1991 Steroid receptors in mammary tumours of the cat. Acta Endocrinologica (Copenhagen) 125 32-37
73. Sartin EA, Barnes S, Kwapien RP et al. 1992 Estrogen and progesterone status of mammary carcinomas and correlation with clinical outcome. American Journal of Veterinary Research 53 2196-2200
74. Scibelli A, d'Angelo D, Pelagalli A, Tafuri S, Avallone L, Della Morte R & Staiano N 2003 Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors. Veterinary Record 34 193-202
75. Simpson JF & Page DL 1992 Prognostic value of histopathology in the breast. Seminars in Oncology 19 254-262
76. Sobin LH & Wittekind CH 1997 International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th Edn. New York: Wiley
77. Speirs V, Malone C, Walton DS, Kerin MJ & Atkin SL 1999 Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Research 59 5421-5424
78. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S & Barsky SH 1997 The human myoepithelial cell is a natural tumor suppressor. Clinical Cancer Research 3 1949-1958
79. Stolwijk JAM, Minke JMHM, Rutteman GR, Hoekstra J, Prop FJA & Misdorp W 1989 Feline mammary carcinomas as a model for human breast cancer. II. Comparison of in vivo and in vitro adriamycin sensitivity. Anticancer Research 9 1045-1048
80. Tanabe S, Nakadai T, Furuoka H, Oomachi T, Kobayashi Y, Omata Y, Koyama T, Hondo E, Uzuka T, Sarashina T, Ducusin RJ, Shida T & Dorf ME 2002 Expression of mRNA of chemokine receptor CXCR4 in feline mammary adenocarcinoma. Veterinary Record 151 729-733
81. Tuck AB, Park M, Sterns EE, Boag A & Elliott BE 1996 American Journal of Pathology 148 225-232
82. Vail DM & MacEwen EG 2000 Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Investigation 18 781-792
83. Valavaara R, Tuominen J & Johansson R 1990 Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with tamoxifen. Cancer 66 2264-2269
84. Van Garderen E, De Wit M, Voorhout WF, Rutteman GR, Mol JA, Nederbragt H & Misdorp W 1997 Expression of growth hormone in canine mammary tumours. American Journal of Pathology 150 1037-1047
85. Weijer K & Hart AAM 1983 Prognostic Factors in feline mammary carcinoma. Journal of the National Cancer Institute 70 709-716
86. Weijer K, Head KW, Misdorp W & Hampe JF 1972 Feline malignant mammary tumours. I. Morphology and biology. Some comparison with human and canine mammary carcinomas. Journal of the National Cancer Institute 49 1696-1704
87. Wellings SR 1980 A hypothesis of human breast cancer from the terminal ductal lobular unit. Pathology Research Practice 166 515-535
88. Young B & Heath JW 2000 Wheater's Functional Histology 4th Edn. Churchill Livingstone